81426-66-6Relevant articles and documents
The first synthesis of geranyllinalool enantiomers
Svatos, Ales,Urbanova, Klara,Valterova, Irena
, p. 83 - 90 (2002)
(3R)-(-)-Geranyllinalool and its (3S)-(+)-isomer were synthesized in 7 steps starting from both enantiomers of citramalic acid and geranyl bromide. The synthetic sequence established the absolute configurations of naturally occurring geranyllinalools for
PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
-
Page/Page column 400-401; 418-419, (2021/06/26)
Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g, protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g, a cancer or a metabolic disease.